NIH #5P20GM121322-08
C/EBPβ in bone marrow stromal cell-mediated drug resistance of multiple myeloma
Active
- Amount
- $253K
- Period
- 2018-08-01 → 2028-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Gangqing Hu
Full Professor(heuristic)
Epigenetics and DNA Methylation · Molecular Biology
h-index41
i10-index81
Publications183
Citations7,422
Grants
5 total · 3 active
NIH #5P20GM121322-07
C/EBPβ in bone marrow stromal cell-mediated drug resistance of multiple myeloma
Active
- Amount
- $260K
- Period
- 2018-08-01 → 2028-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
NIH #2P20GM121322-06
C/EBPβ in bone marrow stromal cell-mediated drug resistance of multiple myeloma
Active
- Amount
- $238K
- Period
- 2018-08-01 → 2028-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Career Trajectory
Research Cluster Map
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
Potential Collaborators
Recent Publications
Last 2 years · showing 3 of 3Optimal CXCR5 expression during Tfh maturation involves the Bhlhe40-Pou2af1 axis
Cell Reports · 2025-10-23 · 3 citations
International Journal of Artificial Intelligence and Robotics Research · 2025-01-01
JMIR Medical Education · 2024-07-23 · 13 citations